Results
The 12 drugs in the recommended scheme (XBCQ) for severe influenza
contain 192 active components and involve 31 key antiviral targets,
which may play an antiviral role through biological processes such as
lipopolysaccharide, pathogen molecular reaction and regulate signaling
pathway via the IL-17, influenza A, TNF, Toll-like receptors.